Blog

SeerPharma Blog listing page

Virtual QA and GMP Consulting

April 06, 2020

For over 30 years SeerPharma has aided Pharmaceutical and Medical Device companies on matters of Quality Assurance and GMP compliance.

The current COVID-19 pandemic is seeing day to day quality related business operations challenged by attempting to deal with multiple personnel across different departments remotely. The need for immediate and...

Read More

Infographic: QA & GMP Compliance Performance Snapshot for 2019

January 08, 2020

INFOGRAPHIC:  A snapshot of how SeerPharma supported its clients in 2019 on matters of Quality Assurance and GMP compliance.

Read More

Infographic: QA & GMP Compliance Performance Snapshot for 2017

January 03, 2018

INFOGRAPHIC:  A snapshot of how SeerPharma has supported its clients in 2017 on matters of QA and GMP compliance.

Read More

International Regulatory Convergence for MTP GMP | 04 April 2017

March 23, 2017

PIC/S Authorities are coming to Melbourne in April 2017 and MTPConnect - the medical technology, biotechnology and pharmaceutical (MTP) Industry Growth Centre - is going to connect the Australian sector with PIC/S event participants.

Read More

Self Inspection for GMP Compliance and Continuous Improvement

March 09, 2017

Self inspection, commonly referred to as an internal audit, is a fundamental part of implementing, maintaining and improving your Pharmaceutical Quality System.  Written into the PIC/S Guide to GMP as chapter 9 due to its criticality, Pharmaceutical manufacturers must ensure their self inspection programme is effective.

Read More

Infographic: QA & GMP Compliance Performance Snapshot for 2016

March 02, 2017

INFOGRAPHIC:  A snapshot of how SeerPharma has supported its clients in 2016 on matters of QA and GMP compliance.

Read More

Pharmaceutical Quality Risk Management in GMP Compliance

February 21, 2017

Quality Risk Management (QRM) is a GMP compliance requirement for Pharmaceutical organisations. The ICH Q9 guideline on Quality Risk Management (Annex 20 of the PIC/S GMP Guide) is expected to be adopted by manufacturers to ensure compliance with clauses 1.12 and 1.13 of Part I of the PIC/S GMP Guide:

Read More

Effective Management of Risk-based GMP for Health Products

February 15, 2017

We're excited to announce the first list of confirmed speakers for our Symposium to be held in Singapore on 16 - 17 March 2017: A Global Perspective on Effective Management of Risk-based GMP for Health Products.

Read More

SeerPharma Sponsors BioMelbourne “Corporate Culture and Risk” Session

December 07, 2016

As part of our commitment to the local biotech sector, SeerPharma was proud to sponsor a BioMelbourne Network session on Corporate Culture and Risk earlier this year.

Read More

Rational GMP Environmental Monitoring

September 26, 2016

Environmental monitoring (EM) of a GMP facility may be conducted for a variety of reasons. The major reasons for conducting EM are to assess the effectiveness of the cleaning program and to assess the impact of the environment on product quality.

Read More